Sandbox 123: Difference between revisions

Revision as of 20:04, 28 April 2014 view source Allison Granberry (talk \| contribs) 742 edits No edit summary ← Older edit		Revision as of 21:24, 28 April 2014 view source Allison Granberry (talk \| contribs) 742 edits No edit summary Newer edit →
Line 58:		Line 58:
	<scene name='36/365380/3zfz_1/8'>allosteric site</scene> (Tyr105, Asn146, Asp295, Tyr297), a conformational change occurs at the active site, opening it and allowing catalytic action to occur.		<scene name='36/365380/3zfz_1/8'>allosteric site</scene> (Tyr105, Asn146, Asp295, Tyr297), a conformational change occurs at the active site, opening it and allowing catalytic action to occur.

	The medicine, <scene name='36/365380/3zfz_1/12'>ceftaroline</scene>, mimics the substrate at the allosteric site opening the active site, allowing ceftaroline to enter and bind noncovalently.		The medicine, <scene name='36/365380/3zfz_1/12'>ceftaroline</scene>, mimics the substrate at the allosteric site opening the active site, allowing ceftaroline to <scene name='36/365380/3zfz_1/13'>enter and bind noncovalently</scene>.

Navigation menu